These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 26443612)

  • 1. Yeast: a microbe with macro-implications to antimicrobial drug discovery.
    Balibar CJ; Roemer T
    Brief Funct Genomics; 2016 Mar; 15(2):147-54. PubMed ID: 26443612
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Genetic Screens for Determination of Mechanism of Action.
    Gay-Andrieu F; Alex D; Calderone R
    Methods Mol Biol; 2016; 1356():165-72. PubMed ID: 26519072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Yeast chemical genomics and drug discovery: an update.
    Hoon S; St Onge RP; Giaever G; Nislow C
    Trends Pharmacol Sci; 2008 Oct; 29(10):499-504. PubMed ID: 18755517
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Genomics strategies for antifungal drug discovery--from gene discovery to compound screening.
    Willins DA; Kessler M; Walker SS; Reyes GR; Cottarel G
    Curr Pharm Des; 2002; 8(13):1137-54. PubMed ID: 12052224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Yeast genomics and proteomics in drug discovery and target validation.
    Parsons AB; Geyer R; Hughes TR; Boone C
    Prog Cell Cycle Res; 2003; 5():159-66. PubMed ID: 14593709
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Chemical genetic and chemogenomic analysis in yeast.
    Coorey NV; Sampson LD; Barber JM; Bellows DS
    Methods Mol Biol; 2014; 1205():169-86. PubMed ID: 25213245
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Yeast genome-wide drug-induced haploinsufficiency screen to determine drug mode of action.
    Baetz K; McHardy L; Gable K; Tarling T; Rebérioux D; Bryan J; Andersen RJ; Dunn T; Hieter P; Roberge M
    Proc Natl Acad Sci U S A; 2004 Mar; 101(13):4525-30. PubMed ID: 15070751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Efforts to make and apply humanized yeast.
    Laurent JM; Young JH; Kachroo AH; Marcotte EM
    Brief Funct Genomics; 2016 Mar; 15(2):155-63. PubMed ID: 26462863
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A survey of yeast genomic assays for drug and target discovery.
    Smith AM; Ammar R; Nislow C; Giaever G
    Pharmacol Ther; 2010 Aug; 127(2):156-64. PubMed ID: 20546776
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The fascinating and secret wild life of the budding yeast S. cerevisiae.
    Liti G
    Elife; 2015 Mar; 4():. PubMed ID: 25807086
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ecological and evolutionary genomics of Saccharomyces cerevisiae.
    Landry CR; Townsend JP; Hartl DL; Cavalieri D
    Mol Ecol; 2006 Mar; 15(3):575-91. PubMed ID: 16499686
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A novel calcineurin-independent activity of cyclosporin A in Saccharomyces cerevisiae.
    Singh-Babak SD; Shekhar T; Smith AM; Giaever G; Nislow C; Cowen LE
    Mol Biosyst; 2012 Oct; 8(10):2575-84. PubMed ID: 22751784
    [TBL] [Abstract][Full Text] [Related]  

  • 13. André Goffeau's imprinting on second generation yeast "genomologists".
    Fairhead C; Fischer G; Liti G; Neuvéglise C; Schacherer J
    Yeast; 2019 Apr; 36(4):167-175. PubMed ID: 30645763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Combining chemical genomics screens in yeast to reveal spectrum of effects of chemical inhibition of sphingolipid biosynthesis.
    Kemmer D; McHardy LM; Hoon S; Rebérioux D; Giaever G; Nislow C; Roskelley CD; Roberge M
    BMC Microbiol; 2009 Jan; 9():9. PubMed ID: 19144191
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Chemical genetics: budding yeast as a platform for drug discovery and mapping of genetic pathways.
    Enserink JM
    Molecules; 2012 Aug; 17(8):9258-73. PubMed ID: 22858845
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The global effect of exposing bakers' yeast to 5-fluoruracil and nystatin; a view to Toxichip.
    Graziano S; Gullì M; Maestri E; Marmiroli N
    Chemosphere; 2016 Feb; 145():470-9. PubMed ID: 26694798
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The rise of yeast population genomics.
    Liti G; Schacherer J
    C R Biol; 2011; 334(8-9):612-9. PubMed ID: 21819942
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional genomics in antibacterial drug discovery.
    Freiberg C; Brötz-Oesterhelt H
    Drug Discov Today; 2005 Jul; 10(13):927-35. PubMed ID: 15993812
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Genome-wide analysis of yeast aging.
    Sutphin GL; Olsen BA; Kennedy BK; Kaeberlein M
    Subcell Biochem; 2012; 57():251-89. PubMed ID: 22094426
    [TBL] [Abstract][Full Text] [Related]  

  • 20. From drug to protein: using yeast genetics for high-throughput target discovery.
    Armour CD; Lum PY
    Curr Opin Chem Biol; 2005 Feb; 9(1):20-4. PubMed ID: 15701448
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.